Microbial Metabolism. Part 11.1) metabolites of flutamide

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 4, 2010, Pages 562-564

  Herath, Wimal ^a   Khan, Ikhlas Ahmad ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Flutamide; Microbial metabolism; Rhodotorula mucilaginosa

Indexed keywords

2 METHYL N [ 4 AMINO 3 (TRIFLUOROMETHYL)PHENYL]PROPANAMIDE; 4 NITRO 3 (TRIFLUOROMETHYL)ANILINE; ACETAMIDE DERIVATIVE; ANILINE DERIVATIVE; FLUTAMIDE; N [ 4 AMINO 3 (TRIFLUOROMETHYL)PHENYL]ACETAMIDE; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CRYSTAL STRUCTURE; DRUG FORMULATION; DRUG METABOLISM; DRUG TRANSFORMATION; FUNGAL STRAIN; FUNGUS CULTURE; HUMAN; MASS SPECTROMETRY; METABOLITE; MICROBIAL METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RHODOTORULA; RHODOTORULA MUCILAGINOSA;

ANTINEOPLASTIC AGENTS, HORMONAL; FLUTAMIDE; HUMANS; MOLECULAR STRUCTURE; RHODOTORULA;

EID: 77950837328     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.562     Document Type: Article

References (18)

1. Part 10: Herath W., Mikell J. R., Khan I. A., Nat. Prod. Res., 23, 1231-1239 (2009).
2. Sortino S., Gluffrida S., De Guidi G., Chillemi R., Petralia S., Marconi G., Condorelli G., Scluto S., Photochem. Photobiol., 73, 6-13 (2001).
3. Goda R., Nagai D., Akiyama Y., Nishikawa K., Ikemoto I., Aizawa Y., Nagata K., Yamazoe Y., Drug Metab. Dispos., 34, 828-835 (2006).
4. Tevell A., Lennernäs H., Jönsson M., Norlin M., Lennernäs B., Bondesson U., Hedeland M., Drug Metab. Dispos., 34, 984-992 (2006).
5. Kang P., Dalvie D., Smith E., Zhou S., Deese A., Drug Metab. Dispos., 35, 1081-1088 (2007).
6. Wen B., Coe K. J., Rademacher P., Fitch W. L., Monshouwer M., Nelson S. D., Chem. Res. Toxicol., 21, 2393-2406 (2008).
7. Aizawa Y., Ikemoto I., Kishimoto K., Wada T., Yamazaki H., Ohishi Y., Kiyota H., Furuta N., Suzuki H., Ueda M., Mol. Cell. Biochem., 252, 149-156 (2003).
8. Kang P., Dalvie D., Smith E., Zhou S., Deese A., Nieman J. A., Drug Metab. Dispos., 36, 1425-1437 (2008).
9. Tzanavaras P. D., Themelis D. G., J. Pharm. Biomed. Anal., 43, 1820-1824 (2007).
10. Marsall K., Altern. Med. Rev., 6, 272-292 (2001).
11. Ozono S., Yamaguchi A., Mochizuki H., Kawakami T., Fujimoto K., Otani T., Yoshida K., Ichinei M., Yamashita T., Hirao Y., Prostate Cancer Prostatic Dis., 5, 128-131 (2002).
12. Herath W., Mikell J. R., Ferreira D., Khan I. A., Chem. Pharm. Bull., 51, 646-648 (2003).
13. Stabile R. G., Dicks A. P., J. Chem. Educ., 80, 1439-1443 (2003).
14. Boelsterli U. A., Ho H. K., Zhou S., Leow K. Y., Curr. Drug Metab., 7, 715-727 (2006).
15. Abourashed E. A., Khan I. A., Chem. Pharm. Bull., 48, 1996-1998 (2000).
16. Elmarakby S. A., Clark A. M., Baker J. K., Hufford C. D., J. Pharm. Sci., 75, 614-618 (1986).
17. Orabi K. Y., Clark A. M., Hufford C. D., J. Nat. Prod., 63, 396-398 (2000).
18. Takashima E., Iguchi K., Usui S., Yamamoto H., Hirano K., Biol. Pharm. Bull., 26, 1455-1460 (2003).